These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 29099502)
1. Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center. Farshid G; Edwards S; Kollias J; Gill PG Mod Pathol; 2018 Mar; 31(3):395-405. PubMed ID: 29099502 [TBL] [Abstract][Full Text] [Related]
2. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision. Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463 [TBL] [Abstract][Full Text] [Related]
3. Type of Architecture, Presence of Punctate Necrosis, and Extent of Involvement in Atypical Ductal Hyperplasia Can Predict the Diagnosis of Breast Carcinoma on Excision: A Clinicopathologic Study of 143 Cases. Zhang C; Wang EY; Liu F; Ruhul Quddus M; James Sung C Int J Surg Pathol; 2021 Oct; 29(7):716-721. PubMed ID: 33881947 [TBL] [Abstract][Full Text] [Related]
4. Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma? Pilewskie M; Stempel M; Rosenfeld H; Eaton A; Van Zee KJ; Morrow M Ann Surg Oncol; 2016 Oct; 23(11):3487-3493. PubMed ID: 27172775 [TBL] [Abstract][Full Text] [Related]
5. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings]. Piubello Q; Montemezzi S; D'Atri C Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993 [TBL] [Abstract][Full Text] [Related]
6. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Yeh IT; Dimitrov D; Otto P; Miller AR; Kahlenberg MS; Cruz A Arch Pathol Lab Med; 2003 Jan; 127(1):49-54. PubMed ID: 12521366 [TBL] [Abstract][Full Text] [Related]
7. Management and risk of upgrade of atypical ductal hyperplasia in the breast: A population-based retrospective cohort study. Wadsten C; Rask G Scand J Surg; 2024 Sep; 113(3):229-236. PubMed ID: 38414163 [TBL] [Abstract][Full Text] [Related]
8. Role of vacuum assisted excision in minimising overtreatment of ductal atypias. McMahon MA; Haigh I; Chen Y; Millican-Slater RA; Sharma N Eur J Radiol; 2020 Oct; 131():109258. PubMed ID: 32919262 [TBL] [Abstract][Full Text] [Related]
9. Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases. Farshid G; Sullivan T; Downey P; Gill PG; Pieterse S Br J Cancer; 2011 Nov; 105(11):1669-75. PubMed ID: 22052156 [TBL] [Abstract][Full Text] [Related]
10. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast. Bofin AM; Lydersen S; Hagmar BM Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery. Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675 [TBL] [Abstract][Full Text] [Related]
12. Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions. Dahlstrom JE; Sutton S; Jain S Histopathology; 1996 Jun; 28(6):537-41. PubMed ID: 8803597 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy. Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647 [TBL] [Abstract][Full Text] [Related]
14. Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsy. Tocino I; Garcia BM; Carter D Ann Surg Oncol; 1996 Sep; 3(5):483-8. PubMed ID: 8876891 [TBL] [Abstract][Full Text] [Related]
15. Atypical Ductal Hyperplasia-Ductal Carcinoma In Situ Spectrum: Diagnostic Considerations and Treatment Impact in the Era of Deescalation. Sanders ME; Podoll MB Surg Pathol Clin; 2022 Mar; 15(1):95-103. PubMed ID: 35236636 [TBL] [Abstract][Full Text] [Related]
16. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy. Catteau X; Simon P; Noël JC Pathol Res Pract; 2012 Apr; 208(4):217-20. PubMed ID: 22445178 [TBL] [Abstract][Full Text] [Related]
17. Atypical hyperplasia in the era of stereotactic core needle biopsy. Brown TA; Wall JW; Christensen ED; Smith DV; Holt CA; Carter PL; Patience TH; Babu SS; Williard WC J Surg Oncol; 1998 Mar; 67(3):168-73. PubMed ID: 9530887 [TBL] [Abstract][Full Text] [Related]
18. Ductal Carcinoma In Situ - Quo Vadis? Peltecu G Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322 [TBL] [Abstract][Full Text] [Related]
19. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. Liberman L; Cohen MA; Dershaw DD; Abramson AF; Hann LE; Rosen PP AJR Am J Roentgenol; 1995 May; 164(5):1111-3. PubMed ID: 7717215 [TBL] [Abstract][Full Text] [Related]
20. Is the upgrade rate of atypical ductal hyperplasia diagnosed by core needle biopsy of calcifications different for digital and film-screen mammography? McLaughlin CT; Neal CH; Helvie MA AJR Am J Roentgenol; 2014 Oct; 203(4):917-22. PubMed ID: 25247961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]